| 000 | 01706 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516074953.0 | ||
| 264 | 0 | _c20120710 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1525-0024 | ||
| 024 | 7 |
_a10.1038/mt.2011.288 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBear, Adham S | |
| 245 | 0 | 0 |
_aReplication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? _h[electronic resource] |
| 260 |
_bMolecular therapy : the journal of the American Society of Gene Therapy _cFeb 2012 |
||
| 300 |
_a246-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aGenetic Therapy _xadverse effects |
| 650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRetroviridae _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
| 650 | 0 | 4 |
_aToxicity Tests _xeconomics |
| 650 | 0 | 4 | _aTransduction, Genetic |
| 650 | 0 | 4 |
_aVirus Replication _xgenetics |
| 700 | 1 | _aMorgan, Richard A | |
| 700 | 1 | _aCornetta, Kenneth | |
| 700 | 1 | _aJune, Carl H | |
| 700 | 1 | _aBinder-Scholl, Gwendolyn | |
| 700 | 1 | _aDudley, Mark E | |
| 700 | 1 | _aFeldman, Steven A | |
| 700 | 1 | _aRosenberg, Steven A | |
| 700 | 1 | _aShurtleff, Sheila A | |
| 700 | 1 | _aRooney, Cliona M | |
| 700 | 1 | _aHeslop, Helen E | |
| 700 | 1 | _aDotti, Gianpietro | |
| 773 | 0 |
_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 20 _gno. 2 _gp. 246-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/mt.2011.288 _zAvailable from publisher's website |
| 999 |
_c21510776 _d21510776 |
||